Literature DB >> 3783887

Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure.

M S Ewer, M K Ali, M S Atta, R C Morice, P V Balakrishnan.   

Abstract

The prognosis of lung cancer patients who are not candidates for surgery is usually poor. The unfavorable natural history of respiratory failure in this group of patients has been suggested as a causative factor. We analyzed the outcome of 46 consecutive patients with primary lung cancer on whom mechanical ventilators were utilized. Although seven patients were ultimately weaned and survived for at least 24 hours, three of them subsequently died prior to discharge from the hospital. The remaining 39 patients died while using the ventilator. Patient age, tumor cell type, and the etiology of respiratory failure were not significantly different between the weaned and unweaned populations. A difference was noted in the duration of mechanical ventilation: none of the patients who could be weaned required mechanical ventilation for more than six days (range, two to six days). Respiratory failure in the nonsurgical lung cancer patient carries a poor prognosis, and selection of patients for mechanical ventilation should be conservative.

Entities:  

Mesh:

Year:  1986        PMID: 3783887

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  18 in total

1.  Dyspnea and cancer: support in agonizing conditions.

Authors:  P Drings
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

2.  Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.

Authors:  Yu Jung Kim; Mi-Jung Kim; Young-Jae Cho; Jong Sun Park; Jin Won Kim; Hyun Chang; Jeong-Ok Lee; Keun-Wook Lee; Jee Hyun Kim; Ho Il Yoon; Soo-Mee Bang; Jae Ho Lee; Choon-Taek Lee; Jong Seok Lee
Journal:  Med Oncol       Date:  2014-01-22       Impact factor: 3.064

3.  Is intensive care justified for patients with haematological malignancies?

Authors:  F Brunet; J J Lanore; J F Dhainaut; F Dreyfus; J F Vaxelaire; S Nouira; T Giraud; A Armaganidis; J F Monsallier
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

4.  Outcome of ICU treatment in invasive aspergillosis.

Authors:  J J Janssen; R J Strack van Schijndel; E H van der Poest Clement; G J Ossenkoppele; L G Thijs; P C Huijgens
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

Review 5.  Aspergillosis in the ICU: the glass half-empty?

Authors:  S W Crawford
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

6.  Trends in end-of-life ICU use among older adults with advanced lung cancer.

Authors:  Gulshan Sharma; Jean Freeman; Dong Zhang; James S Goodwin
Journal:  Chest       Date:  2007-11-07       Impact factor: 9.410

7.  Six-month prognosis of patients with lung cancer admitted to the intensive care unit.

Authors:  Sébastien Roques; Antoine Parrot; Armelle Lavole; Pierre-Yves Ancel; Valérie Gounant; Michel Djibre; Muriel Fartoukh
Journal:  Intensive Care Med       Date:  2009-09-19       Impact factor: 17.440

Review 8.  Endoscopic management of acute respiratory failure related to tracheobronchial malignancies.

Authors:  V Ninane
Journal:  Support Care Cancer       Date:  1995-11       Impact factor: 3.603

9.  Treatment of Lung Cancer Patients With Actionable Mutations in the Intensive Care Unit.

Authors:  Kathleen Kerrigan; Abigail Shoben; Gregory Otterson
Journal:  Clin Lung Cancer       Date:  2016-05-05       Impact factor: 4.785

10.  Outcome of lung cancer patients admitted to the intensive care unit with acute respiratory failure.

Authors:  S Anisoglou; C Asteriou; N Barbetakis; S Kakolyris; G Anastasiadou; I Pnevmatikos
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.